Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Visualizing the Distribution of Matrix Metalloproteinases in Ischemic Brain Using In Vivo 19F-Magnetic Resonance Spectroscopic Imaging.

Huber VJ, Igarashi H, Ueki S, Terumitsu-Tsujita M, Nito C, Ohno K, Suzuki Y, Itoh K, Kwee IL, Nakada T.

Contrast Media Mol Imaging. 2019 Jan 6;2019:8908943. doi: 10.1155/2019/8908943. eCollection 2019.

2.

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.

Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach JM, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, Blenkiron C, Bobis-Wozowicz S, Boilard E, Boireau W, Bongiovanni A, Borràs FE, Bosch S, Boulanger CM, Breakefield X, Breglio AM, Brennan MÁ, Brigstock DR, Brisson A, Broekman ML, Bromberg JF, Bryl-Górecka P, Buch S, Buck AH, Burger D, Busatto S, Buschmann D, Bussolati B, Buzás EI, Byrd JB, Camussi G, Carter DR, Caruso S, Chamley LW, Chang YT, Chen C, Chen S, Cheng L, Chin AR, Clayton A, Clerici SP, Cocks A, Cocucci E, Coffey RJ, Cordeiro-da-Silva A, Couch Y, Coumans FA, Coyle B, Crescitelli R, Criado MF, D'Souza-Schorey C, Das S, Datta Chaudhuri A, de Candia P, De Santana EF, De Wever O, Del Portillo HA, Demaret T, Deville S, Devitt A, Dhondt B, Di Vizio D, Dieterich LC, Dolo V, Dominguez Rubio AP, Dominici M, Dourado MR, Driedonks TA, Duarte FV, Duncan HM, Eichenberger RM, Ekström K, El Andaloussi S, Elie-Caille C, Erdbrügger U, Falcón-Pérez JM, Fatima F, Fish JE, Flores-Bellver M, Försönits A, Frelet-Barrand A, Fricke F, Fuhrmann G, Gabrielsson S, Gámez-Valero A, Gardiner C, Gärtner K, Gaudin R, Gho YS, Giebel B, Gilbert C, Gimona M, Giusti I, Goberdhan DC, Görgens A, Gorski SM, Greening DW, Gross JC, Gualerzi A, Gupta GN, Gustafson D, Handberg A, Haraszti RA, Harrison P, Hegyesi H, Hendrix A, Hill AF, Hochberg FH, Hoffmann KF, Holder B, Holthofer H, Hosseinkhani B, Hu G, Huang Y, Huber V, Hunt S, Ibrahim AG, Ikezu T, Inal JM, Isin M, Ivanova A, Jackson HK, Jacobsen S, Jay SM, Jayachandran M, Jenster G, Jiang L, Johnson SM, Jones JC, Jong A, Jovanovic-Talisman T, Jung S, Kalluri R, Kano SI, Kaur S, Kawamura Y, Keller ET, Khamari D, Khomyakova E, Khvorova A, Kierulf P, Kim KP, Kislinger T, Klingeborn M, Klinke DJ 2nd, Kornek M, Kosanović MM, Kovács ÁF, Krämer-Albers EM, Krasemann S, Krause M, Kurochkin IV, Kusuma GD, Kuypers S, Laitinen S, Langevin SM, Languino LR, Lannigan J, Lässer C, Laurent LC, Lavieu G, Lázaro-Ibáñez E, Le Lay S, Lee MS, Lee YXF, Lemos DS, Lenassi M, Leszczynska A, Li IT, Liao K, Libregts SF, Ligeti E, Lim R, Lim SK, Linē A, Linnemannstöns K, Llorente A, Lombard CA, Lorenowicz MJ, Lörincz ÁM, Lötvall J, Lovett J, Lowry MC, Loyer X, Lu Q, Lukomska B, Lunavat TR, Maas SL, Malhi H, Marcilla A, Mariani J, Mariscal J, Martens-Uzunova ES, Martin-Jaular L, Martinez MC, Martins VR, Mathieu M, Mathivanan S, Maugeri M, McGinnis LK, McVey MJ, Meckes DG Jr, Meehan KL, Mertens I, Minciacchi VR, Möller A, Møller Jørgensen M, Morales-Kastresana A, Morhayim J, Mullier F, Muraca M, Musante L, Mussack V, Muth DC, Myburgh KH, Najrana T, Nawaz M, Nazarenko I, Nejsum P, Neri C, Neri T, Nieuwland R, Nimrichter L, Nolan JP, Nolte-'t Hoen EN, Noren Hooten N, O'Driscoll L, O'Grady T, O'Loghlen A, Ochiya T, Olivier M, Ortiz A, Ortiz LA, Osteikoetxea X, Østergaard O, Ostrowski M, Park J, Pegtel DM, Peinado H, Perut F, Pfaffl MW, Phinney DG, Pieters BC, Pink RC, Pisetsky DS, Pogge von Strandmann E, Polakovicova I, Poon IK, Powell BH, Prada I, Pulliam L, Quesenberry P, Radeghieri A, Raffai RL, Raimondo S, Rak J, Ramirez MI, Raposo G, Rayyan MS, Regev-Rudzki N, Ricklefs FL, Robbins PD, Roberts DD, Rodrigues SC, Rohde E, Rome S, Rouschop KM, Rughetti A, Russell AE, Saá P, Sahoo S, Salas-Huenuleo E, Sánchez C, Saugstad JA, Saul MJ, Schiffelers RM, Schneider R, Schøyen TH, Scott A, Shahaj E, Sharma S, Shatnyeva O, Shekari F, Shelke GV, Shetty AK, Shiba K, Siljander PR, Silva AM, Skowronek A, Snyder OL 2nd, Soares RP, Sódar BW, Soekmadji C, Sotillo J, Stahl PD, Stoorvogel W, Stott SL, Strasser EF, Swift S, Tahara H, Tewari M, Timms K, Tiwari S, Tixeira R, Tkach M, Toh WS, Tomasini R, Torrecilhas AC, Tosar JP, Toxavidis V, Urbanelli L, Vader P, van Balkom BW, van der Grein SG, Van Deun J, van Herwijnen MJ, Van Keuren-Jensen K, van Niel G, van Royen ME, van Wijnen AJ, Vasconcelos MH, Vechetti IJ Jr, Veit TD, Vella LJ, Velot É, Verweij FJ, Vestad B, Viñas JL, Visnovitz T, Vukman KV, Wahlgren J, Watson DC, Wauben MH, Weaver A, Webber JP, Weber V, Wehman AM, Weiss DJ, Welsh JA, Wendt S, Wheelock AM, Wiener Z, Witte L, Wolfram J, Xagorari A, Xander P, Xu J, Yan X, Yáñez-Mó M, Yin H, Yuana Y, Zappulli V, Zarubova J, Žėkas V, Zhang JY, Zhao Z, Zheng L, Zheutlin AR, Zickler AM, Zimmermann P, Zivkovic AM, Zocco D, Zuba-Surma EK.

J Extracell Vesicles. 2018 Nov 23;7(1):1535750. doi: 10.1080/20013078.2018.1535750. eCollection 2018.

3.

Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk.

Fortunato O, Borzi C, Milione M, Centonze G, Conte D, Boeri M, Verri C, Moro M, Facchinetti F, Andriani F, Roz L, Caleca L, Huber V, Cova A, Camisaschi C, Castelli C, Cancila V, Tripodo C, Pastorino U, Sozzi G.

Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31988. [Epub ahead of print]

PMID:
30426475
4.

Temperature-related mortality impacts under and beyond Paris Agreement climate change scenarios.

Vicedo-Cabrera AM, Guo Y, Sera F, Huber V, Schleussner CF, Mitchell D, Tong S, de Sousa Zanotti Stagliorio Coelho M, Saldiva PHN, Lavigne E, Correa PM, Ortega NV, Kan H, Osorio S, Kyselý J, Urban A, Jaakkola JJK, Ryti NRI, Pascal M, Goodman PG, Zeka A, Michelozzi P, Scortichini M, Hashizume M, Honda Y, Hurtado-Diaz M, Cruz J, Seposo X, Kim H, Tobias A, Íñiguez C, Forsberg B, Åström DO, Ragettli MS, Röösli M, Guo YL, Wu CF, Zanobetti A, Schwartz J, Bell ML, Dang TN, Van DD, Heaviside C, Vardoulakis S, Hajat S, Haines A, Armstrong B, Ebi KL, Gasparrini A.

Clim Change. 2018 Oct;150(3-4):391-402. doi: 10.1007/s10584-018-2274-3. Epub 2018 Sep 13.

5.

Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy.

Tuccitto A, Shahaj E, Vergani E, Ferro S, Huber V, Rodolfo M, Castelli C, Rivoltini L, Vallacchi V.

Virchows Arch. 2018 Oct 29. doi: 10.1007/s00428-018-2477-z. [Epub ahead of print] Review.

PMID:
30374798
6.

A novel computational method for automatic segmentation, quantification and comparative analysis of immunohistochemically labeled tissue sections.

Casiraghi E, Huber V, Frasca M, Cossa M, Tozzi M, Rivoltini L, Leone BE, Villa A, Vergani B.

BMC Bioinformatics. 2018 Oct 15;19(Suppl 10):357. doi: 10.1186/s12859-018-2302-3.

7.

CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia.

Lewinsky H, Barak AF, Huber V, Kramer MP, Radomir L, Sever L, Orr I, Mirkin V, Dezorella N, Shapiro M, Cohen Y, Shvidel L, Seiffert M, Herishanu Y, Becker-Herman S, Shachar I.

J Clin Invest. 2018 Dec 3;128(12):5465-5478. doi: 10.1172/JCI96610. Epub 2018 Nov 5.

8.

Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.

Huber V, Vallacchi V, Fleming V, Hu X, Cova A, Dugo M, Shahaj E, Sulsenti R, Vergani E, Filipazzi P, De Laurentiis A, Lalli L, Di Guardo L, Patuzzo R, Vergani B, Casiraghi E, Cossa M, Gualeni A, Bollati V, Arienti F, De Braud F, Mariani L, Villa A, Altevogt P, Umansky V, Rodolfo M, Rivoltini L.

J Clin Invest. 2018 Dec 3;128(12):5505-5516. doi: 10.1172/JCI98060. Epub 2018 Nov 5.

9.

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade.

Lo Russo G, Moro M, Sommariva M, Cancila V, Boeri M, Centonze G, Ferro S, Ganzinelli M, Gasparini P, Huber V, Milione M, Porcu L, Proto C, Pruneri G, Signorelli D, Sangaletti S, Sfondrini L, Storti C, Tassi E, Bardelli A, Marsoni S, Torri V, Tripodo C, Colombo MP, Anichini A, Rivoltini L, Balsari A, Sozzi G, Garassino MC.

Clin Cancer Res. 2019 Feb 1;25(3):989-999. doi: 10.1158/1078-0432.CCR-18-1390. Epub 2018 Sep 11.

PMID:
30206165
10.

Mechanisms of tumor immunotherapy, with a focus on thoracic cancers.

Ferro S, Huber V, Rivoltini L.

J Thorac Dis. 2018 Jul;10(7):4619-4631. doi: 10.21037/jtd.2018.07.30. Review.

11.

The Streptococcus pyogenes fibronectin/tenascin-binding protein PrtF.2 contributes to virulence in an influenza superinfection.

Herrera AL, Faal H, Moss D, Addengast L, Fanta L, Eyster K, Huber VC, Chaussee MS.

Sci Rep. 2018 Aug 14;8(1):12126. doi: 10.1038/s41598-018-29714-x.

12.

pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma.

Kuchuk O, Tuccitto A, Citterio D, Huber V, Camisaschi C, Milione M, Vergani B, Villa A, Alison MR, Carradori S, Supuran CT, Rivoltini L, Castelli C, Mazzaferro V.

Oncoimmunology. 2018 Mar 26;7(7):e1445452. doi: 10.1080/2162402X.2018.1445452. eCollection 2018.

13.

The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer.

Vernieri C, Mennitto A, Prisciandaro M, Huber V, Milano M, Rinaldi L, Cona MS, Maggi C, Ferrari B, Manoukian S, Mariani G, Bianchi G, Capri G, Rivoltini L, de Braud F.

Sci Rep. 2018 Jun 7;8(1):8703. doi: 10.1038/s41598-018-27075-z.

14.

Contributions of Influenza Virus Hemagglutinin and Host Immune Responses Toward the Severity of Influenza Virus: Streptococcus pyogenes Superinfections.

Klonoski JM, Watson T, Bickett TE, Svendsen JM, Gau TJ, Britt A, Nelson JT, Schlenker EH, Chaussee MS, Rynda-Apple A, Huber VC.

Viral Immunol. 2018 Jul/Aug;31(6):457-469. doi: 10.1089/vim.2017.0193. Epub 2018 Jun 5.

PMID:
29870311
15.

Aquaporin-4 facilitator TGN-073 promotes interstitial fluid circulation within the blood-brain barrier: [17O]H2O JJVCPE MRI study.

Huber VJ, Igarashi H, Ueki S, Kwee IL, Nakada T.

Neuroreport. 2018 Jun 13;29(9):697-703. doi: 10.1097/WNR.0000000000000990.

16.

Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.

Schultz K, Jelusic D, Wittmann M, Krämer B, Huber V, Fuchs S, Lehbert N, Wingart S, Stojanovic D, Göhl O, Alma HJ, de Jong C, van der Molen T, Faller H, Schuler M.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702000. doi: 10.1183/13993003.02000-2017. Print 2018 Jan.

PMID:
29371382
17.

MIAQuant, a novel system for automatic segmentation, measurement, and localization comparison of different biomarkers from serialized histological slices.

Casiraghi E, Cossa M, Huber V, Rivoltini L, Tozzi M, Villa A, Vergani B.

Eur J Histochem. 2017 Nov 2;61(4):2838. doi: 10.4081/ejh.2017.2838.

18.

Projections of temperature-related excess mortality under climate change scenarios.

Gasparrini A, Guo Y, Sera F, Vicedo-Cabrera AM, Huber V, Tong S, de Sousa Zanotti Stagliorio Coelho M, Nascimento Saldiva PH, Lavigne E, Matus Correa P, Valdes Ortega N, Kan H, Osorio S, Kyselý J, Urban A, Jaakkola JJK, Ryti NRI, Pascal M, Goodman PG, Zeka A, Michelozzi P, Scortichini M, Hashizume M, Honda Y, Hurtado-Diaz M, Cesar Cruz J, Seposo X, Kim H, Tobias A, Iñiguez C, Forsberg B, Åström DO, Ragettli MS, Guo YL, Wu CF, Zanobetti A, Schwartz J, Bell ML, Dang TN, Van DD, Heaviside C, Vardoulakis S, Hajat S, Haines A, Armstrong B.

Lancet Planet Health. 2017 Dec;1(9):e360-e367. doi: 10.1016/S2542-5196(17)30156-0.

19.

The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Smith AM, Huber VC.

Viral Immunol. 2018 Mar;31(2):159-173. doi: 10.1089/vim.2017.0138. Epub 2017 Nov 17. Review.

PMID:
29148920
20.

Binding host proteins to the M protein contributes to the mortality associated with influenza-Streptococcus pyogenes superinfections.

Herrera AL, Suso K, Allison S, Simon A, Schlenker E, Huber VC, Chaussee MS.

Microbiology. 2017 Sep 25. doi: 10.1099/mic.0.000532. [Epub ahead of print]

21.

So You Want To Be A Reviewer.

Vogt HB, Huber VC, Hansen KA.

S D Med. 2017 Mar;70(3):127-133.

PMID:
28813775
22.

Aquaporin Positron Emission Tomography Differentiates Between Grade III and IV Human Astrocytoma.

Suzuki Y, Nakamura Y, Yamada K, Kurabe S, Okamoto K, Aoki H, Kitaura H, Kakita A, Fujii Y, Huber VJ, Igarashi H, Kwee IL, Nakada T.

Neurosurgery. 2018 Jun 1;82(6):842-846. doi: 10.1093/neuros/nyx314.

23.

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation.

Huber V, Camisaschi C, Berzi A, Ferro S, Lugini L, Triulzi T, Tuccitto A, Tagliabue E, Castelli C, Rivoltini L.

Semin Cancer Biol. 2017 Apr;43:74-89. doi: 10.1016/j.semcancer.2017.03.001. Epub 2017 Mar 6. Review.

24.

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.

Vallacchi V, Camisaschi C, Dugo M, Vergani E, Deho P, Gualeni A, Huber V, Gloghini A, Maurichi A, Santinami M, Sensi M, Castelli C, Rivoltini L, Rodolfo M.

Genes (Basel). 2016 Dec 14;7(12). pii: E124.

25.

Publisher's Note: "In-vessel calibration of the imaging diagnostics for the real-time protection of the JET ITER-like wall" [Rev. Sci. Instrum. 87, 11D430 (2016)].

Huber V, Huber A, Kinna D, Balboa I, Collins S, Conway N, Drewelow P, Maggi CF, Matthews GF, Meigs AG, Mertens P, Price M, Sergienko G, Silburn S, Wynn A, Zastrow KD.

Rev Sci Instrum. 2016 Nov;87(11):11F903. No abstract available.

PMID:
27910683
26.

Recent developments of in-vessel calibration of mid-IR cameras at JET.

Balboa I, Silburn S, Drewelow P, Huber V, Huber A, Kinna D, Price M, Matthews GF, Collins S, Fessey J, Rack M, Trimble P, Zastrow KD.

Rev Sci Instrum. 2016 Nov;87(11):11D419.

PMID:
27910440
27.

In-vessel calibration of the imaging diagnostics for the real-time protection of the JET ITER-like wall.

Huber V, Huber A, Kinna D, Balboa I, Collins S, Conway N, Drewelow P, Maggi CF, Matthews GF, Meigs AG, Mertens P, Price M, Sergienko G, Silburn S, Wynn A, Zastrow KD.

Rev Sci Instrum. 2016 Nov;87(11):11D430. Erratum in: Rev Sci Instrum. 2016 Nov;87(11):11F903.

PMID:
27910322
28.

Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses.

Wang Z, Kedzierski L, Nuessing S, Chua BY, Quiñones-Parra SM, Huber VC, Jackson DC, Thomas PG, Kedzierska K.

J Gen Virol. 2016 Dec;97(12):3205-3214. doi: 10.1099/jgv.0.000651. Epub 2016 Nov 2.

PMID:
27902386
29.

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

Ascierto PA, Agarwala S, Botti G, Cesano A, Ciliberto G, Davies MA, Demaria S, Dummer R, Eggermont AM, Ferrone S, Fu YX, Gajewski TF, Garbe C, Huber V, Khleif S, Krauthammer M, Lo RS, Masucci G, Palmieri G, Postow M, Puzanov I, Silk A, Spranger S, Stroncek DF, Tarhini A, Taube JM, Testori A, Wang E, Wargo JA, Yee C, Zarour H, Zitvogel L, Fox BA, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2016 Nov 15;14(1):313.

30.

Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer.

Camisaschi C, Vallacchi V, Vergani E, Tazzari M, Ferro S, Tuccitto A, Kuchuk O, Shahaj E, Sulsenti R, Castelli C, Rodolfo M, Rivoltini L, Huber V.

Vaccines (Basel). 2016 Nov 4;4(4). pii: E38. Review.

31.

Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.

Bossi P, Bergamini C, Miceli R, Cova A, Orlandi E, Resteghini C, Locati L, Alfieri S, Imbimbo M, Granata R, Mariani L, Iacovelli NA, Huber V, Cavallo A, Licitra L, Rivoltini L.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):959-966. doi: 10.1016/j.ijrobp.2016.08.047. Epub 2016 Sep 6.

PMID:
27745982
33.

Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.

Shepardson KM, Larson K, Morton RV, Prigge JR, Schmidt EE, Huber VC, Rynda-Apple A.

MBio. 2016 May 3;7(3). pii: e00506-16. doi: 10.1128/mBio.00506-16.

35.

The Association between Invasive Group A Streptococcal Diseases and Viral Respiratory Tract Infections.

Herrera AL, Huber VC, Chaussee MS.

Front Microbiol. 2016 Mar 21;7:342. doi: 10.3389/fmicb.2016.00342. eCollection 2016. Review.

36.

TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site.

Rivoltini L, Chiodoni C, Squarcina P, Tortoreto M, Villa A, Vergani B, Bürdek M, Botti L, Arioli I, Cova A, Mauri G, Vergani E, Bianchi B, Della Mina P, Cantone L, Bollati V, Zaffaroni N, Gianni AM, Colombo MP, Huber V.

Clin Cancer Res. 2016 Jul 15;22(14):3499-512. doi: 10.1158/1078-0432.CCR-15-2170. Epub 2016 Mar 4.

37.

Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype Viruses.

McCormick K, Jiang Z, Zhu L, Lawson SR, Langenhorst R, Ransburgh R, Brunick C, Tracy MC, Hurtig HR, Mabee LM, Mingo M, Li Y, Webby RJ, Huber VC, Fang Y.

PLoS One. 2015 Jun 10;10(6):e0127649. doi: 10.1371/journal.pone.0127649. eCollection 2015.

38.

N-acetylaspartate decrease in acute stage of ischemic stroke: a perspective from experimental and clinical studies.

Igarashi H, Suzuki Y, Huber VJ, Ida M, Nakada T.

Magn Reson Med Sci. 2015;14(1):13-24. doi: 10.2463/mrms.2014-0039. Epub 2014 Dec 15. Review.

39.

Ligand-based molecular MRI: O-17 JJVCPE amyloid imaging in transgenic mice.

Suzuki K, Igarashi H, Huber VJ, Kitaura H, Kwee IL, Nakada T.

J Neuroimaging. 2014 Nov-Dec;24(6):595-598. doi: 10.1111/jon.12091. Epub 2014 Feb 23.

40.

Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy.

Tazzari M, Negri T, Rini F, Vergani B, Huber V, Villa A, Dagrada P, Colombo C, Fiore M, Gronchi A, Stacchiotti S, Casali PG, Pilotti S, Rivoltini L, Castelli C.

Br J Cancer. 2014 Sep 23;111(7):1350-62. doi: 10.1038/bjc.2014.437. Epub 2014 Aug 7.

41.

Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection.

Klonoski JM, Hurtig HR, Juber BA, Schuneman MJ, Bickett TE, Svendsen JM, Burum B, Penfound TA, Sereda G, Dale JB, Chaussee MS, Huber VC.

Vaccine. 2014 Sep 8;32(40):5241-9. doi: 10.1016/j.vaccine.2014.06.093. Epub 2014 Jul 29.

42.

Enhanced response to pulmonary Streptococcus pneumoniae infection is associated with primary ciliary dyskinesia in mice lacking Pcdp1 and Spef2.

McKenzie CW, Klonoski JM, Maier T, Trujillo G, Vitiello PF, Huber VC, Lee L.

Cilia. 2013 Dec 20;2(1):18. doi: 10.1186/2046-2530-2-18.

43.

The Inter-Sectoral Impact Model Intercomparison Project (ISI-MIP): project framework.

Warszawski L, Frieler K, Huber V, Piontek F, Serdeczny O, Schewe J.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3228-32. doi: 10.1073/pnas.1312330110. Epub 2013 Dec 16.

44.

Influenza vaccines: from whole virus preparations to recombinant protein technology.

Huber VC.

Expert Rev Vaccines. 2014 Jan;13(1):31-42. doi: 10.1586/14760584.2014.852476. Review.

PMID:
24192014
45.

Peripheral blood CD56(bright) NK cells respond to stem cell factor and adhere to its membrane-bound form after upregulation of c-kit.

Pradier A, Tabone-Eglinger S, Huber V, Bosshard C, Rigal E, Wehrle-Haller B, Roosnek E.

Eur J Immunol. 2014 Feb;44(2):511-20. doi: 10.1002/eji.201343868. Epub 2013 Nov 20.

46.

Alloying and Structure of Ultrathin Gallium Films on the (111) and (110) Surfaces of Palladium.

Stadlmayr W, Huber V, Penner S, Klötzer B, Memmel N.

J Phys Chem C Nanomater Interfaces. 2013 Sep 26;117(38):19558-19567. Epub 2013 Sep 2.

47.

Sphingosine 1-phosphate counteracts the effects of interleukin-1β in human chondrocytes.

Stradner MH, Gruber G, Angerer H, Huber V, Setznagl D, Kremser ML, Moazedi-Fürst FC, Windhager R, Graninger WB.

Arthritis Rheum. 2013 Aug;65(8):2113-22. doi: 10.1002/art.37989.

48.

Construction and immunogenicity evaluation of an epitope-based antigen against swine influenza A virus using Escherichia coli heat-labile toxin B subunit as a carrier-adjuvant.

Sun Z, Lawson S, Langenhorst R, McCormick KL, Brunick C, Opriessnig T, Baker R, Yoon KJ, Zhang W, Huber VC, Fang Y.

Vet Microbiol. 2013 Jun 28;164(3-4):229-38. doi: 10.1016/j.vetmic.2013.02.010. Epub 2013 Feb 26.

PMID:
23497910
49.

Can surveillance of the influenza virus PB1-F2 gene be used to predict the severity of secondary bacterial infections?

Huber VC.

Virulence. 2012 Oct 1;3(6):523-4. doi: 10.4161/viru.21811. Epub 2012 Oct 1. No abstract available.

50.

Immune surveillance properties of human NK cell-derived exosomes.

Lugini L, Cecchetti S, Huber V, Luciani F, Macchia G, Spadaro F, Paris L, Abalsamo L, Colone M, Molinari A, Podo F, Rivoltini L, Ramoni C, Fais S.

J Immunol. 2012 Sep 15;189(6):2833-42. doi: 10.4049/jimmunol.1101988. Epub 2012 Aug 17.

Supplemental Content

Support Center